| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.806 | 0.005 | 0.806 | Antiobesity | 0.486 0.04 CID_6452977 | ||
| 0.615 | 0.006 | 0.615 | GABA C receptor rho-3 antagonist | 0.539 0.017 CID_6452977 | ||
| 0.555 | 0.019 | 0.555 | 5 Hydroxytryptamine release stimulant | 0.376 0.051 CID_6452977 | ||
| 0.537 | 0.022 | 0.537 | 5 Hydroxytryptamine release inhibitor | 0.442 0.055 CID_6452977 | ||
| 0.496 | 0.033 | 0.496 | Aldehyde oxidase inhibitor | 0.441 0.041 CID_6452977 | ||
| 0.498 | 0.05 | 0.498 | Analgesic | |||
| 0.475 | 0.046 | 0.475 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.311 0.199 CID_6452977 | ||
| 0.457 | 0.039 | 0.457 | Cholesterol antagonist | 0.367 0.058 CID_6452977 | ||
| 0.421 | 0.005 | 0.421 | Glutamate receptor antagonist | 0.287 0.011 CID_6452977 | ||
| 0.407 | 0.013 | 0.407 | 5 Hydroxytryptamine uptake stimulant | 0.333 0.031 CID_6452977 | ||
| 0.447 | 0.068 | 0.447 | Cyclophilin D inhibitor | 0.262 0.2 CID_6452977 | ||
| 0.396 | 0.021 | 0.479 | Peroxidase inhibitor | 0.479 0.011 CID_6452977 | CID_6452977 | |
| 0.392 | 0.027 | 0.392 | Calcium channel activator | 0.305 0.086 CID_6452977 | ||
| 0.365 | 0.003 | 0.365 | Glutamate release inhibitor | 0.252 0.004 CID_6452977 | ||
| 0.361 | 0.011 | 0.361 | Alpha-N-acetylglucosaminidase inhibitor | 0.253 0.022 CID_6452977 | ||
| 0.38 | 0.041 | 0.38 | Aryl hydrocarbon receptor agonist | 0.227 0.089 CID_6452977 | ||
| 0.369 | 0.032 | 0.369 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.335 | 0.005 | 0.335 | Aminoacyl-tRNA synthetase inhibitor | 0.158 0.017 CID_6452977 | ||
| 0.325 | 0.009 | 0.325 | UDP-glucose 4-epimerase inhibitor | 0.281 0.011 CID_6452977 | ||
| 0.322 | 0.008 | 0.322 | Succinate dehydrogenase inhibitor | 0.296 0.011 CID_6452977 | ||
| 0.315 | 0.008 | 0.315 | 5 Hydroxytryptamine agonist | 0.074 0.044 CID_6452977 | ||
| 0.315 | 0.008 | 0.323 | Cystathionine beta-synthase inhibitor | 0.323 0.008 CID_6452977 | CID_6452977 | |
| 0.308 | 0.007 | 0.308 | Ferrochelatase inhibitor | 0.155 0.036 CID_6452977 | ||
| 0.325 | 0.027 | 0.325 | RNA-directed DNA polymerase inhibitor | 0.259 0.045 CID_6452977 | ||
| 0.318 | 0.021 | 0.318 | MAP-kinase-activated kinase 5 inhibitor | 0.167 0.153 CID_6452977 | ||
| 0.32 | 0.025 | 0.32 | Tyrosine 3 hydroxylase inhibitor | 0.302 0.032 CID_6452977 | ||
| 0.35 | 0.062 | 0.35 | Streptokinase A inhibitor | 0.29 0.083 CID_6452977 | ||
| 0.316 | 0.036 | 0.316 | Anticonvulsant | |||
| 0.278 | 0.003 | 0.278 | Lanosterol 14 alpha demethylase inhibitor | 0.192 0.005 CID_6452977 | ||
| 0.305 | 0.032 | 0.305 | Anesthetic general | 0.226 0.061 CID_6452977 | ||
| 0.276 | 0.005 | 0.276 | Nav1.8 sodium channel blocker | 0.092 0.033 CID_6452977 | ||
| 0.281 | 0.011 | 0.281 | GABA C receptor agonist | 0.206 0.019 CID_6452977 | ||
| 0.274 | 0.008 | 0.274 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.182 0.019 CID_6452977 | ||
| 0.385 | 0.12 | 0.385 | Caspase 9 stimulant | 0.383 0.122 CID_6452977 | ||
| 0.266 | 0.003 | 0.266 | Aryl hydrocarbon receptor antagonist | 0.139 0.005 CID_6452977 | ||
| 0.279 | 0.018 | 0.279 | Nitric-oxide synthase stimulant | 0.244 0.036 CID_6452977 | ||
| 0.255 | 0.005 | 0.255 | Cannabinoid receptor antagonist | 0.078 0.041 CID_6452977 | ||
| 0.287 | 0.039 | 0.287 | 5 Hydroxytryptamine 1E antagonist | 0.207 0.123 CID_6452977 | ||
| 0.258 | 0.01 | 0.258 | Mannose-6-phosphate isomerase inhibitor | 0.252 0.012 CID_6452977 | ||
| 0.273 | 0.027 | 0.273 | Neurotrophic factor enhancer | 0.254 0.036 CID_6452977 | ||
| 0.259 | 0.016 | 0.268 | Cholesterol synthesis inhibitor | 0.268 0.015 CID_6452977 | CID_6452977 | |
| 0.247 | 0.005 | 0.247 | Adrenaline uptake inhibitor | 0.178 0.007 CID_6452977 | ||
| 0.288 | 0.046 | 0.288 | Psychostimulant | 0.147 0.119 CID_6452977 | ||
| 0.25 | 0.008 | 0.25 | 5 Hydroxytryptamine uptake inhibitor | 0.099 0.027 CID_6452977 | ||
| 0.245 | 0.005 | 0.245 | Potassium channel large-conductance Ca-activated activator | 0.136 0.013 CID_6452977 | ||
| 0.251 | 0.011 | 0.251 | GABA C receptor rho-2 antagonist | 0.185 0.038 CID_6452977 | ||
| 0.241 | 0.009 | 0.241 | Potassium channel (Ca-activated) activator | 0.19 0.017 CID_6452977 | ||
| 0.245 | 0.015 | 0.245 | ATPase inhibitor | 0.189 0.047 CID_6452977 | ||
| 0.244 | 0.019 | 0.244 | 5 Hydroxytryptamine 3E antagonist | 0.174 0.123 CID_6452977 | ||
| 0.237 | 0.012 | 0.237 | MAP kinase 13 inhibitor | |||
| 0.226 | 0.005 | 0.226 | Cannabinoid CB1 receptor antagonist | 0.077 0.029 CID_6452977 | ||
| 0.276 | 0.056 | 0.276 | HERG channel blocker | |||
| 0.222 | 0.005 | 0.222 | CYP2A6 inhibitor | 0.109 0.031 CID_6452977 | ||
| 0.23 | 0.014 | 0.23 | Chemokine receptor antagonist | |||
| 0.271 | 0.057 | 0.271 | Potassium channel blocker | |||
| 0.229 | 0.014 | 0.229 | Carbonic anhydrase XV inhibitor | 0.171 0.024 CID_6452977 | ||
| 0.22 | 0.006 | 0.22 | Electrolyte absorption antagonist | 0.18 0.011 CID_6452977 | ||
| 0.23 | 0.016 | 0.23 | Catenin beta inhibitor | 0.165 0.074 CID_6452977 | ||
| 0.242 | 0.029 | 0.378 | Heat shock protein 90 alpha antagonist | 0.378 0.006 CID_6452977 | CID_6452977 | |
| 0.232 | 0.019 | 0.232 | Sodium channel (voltage-gated) blocker | 0.11 0.096 CID_6452977 | ||
| 0.223 | 0.011 | 0.24 | NMDA receptor antagonist | 0.24 0.01 CID_6452977 | CID_6452977 | |
| 0.315 | 0.105 | 0.315 | Calpain 2 inhibitor | |||
| 0.219 | 0.01 | 0.219 | 5 Hydroxytryptamine 3A agonist | 0.133 0.046 CID_6452977 | ||
| 0.218 | 0.01 | 0.218 | CC chemokine receptor antagonist | |||
| 0.23 | 0.023 | 0.23 | Sodium channel blocker | 0.119 0.085 CID_6452977 | ||
| 0.209 | 0.007 | 0.209 | Sphingosine 1-phosphate receptor 4 antagonist | 0.177 0.016 CID_6452977 | ||
| 0.219 | 0.017 | 0.219 | MAP kinase 12 inhibitor | 0.101 0.097 CID_6452977 | ||
| 0.212 | 0.011 | 0.212 | GABA C receptor antagonist | 0.153 0.028 CID_6452977 | ||
| 0.245 | 0.045 | 0.245 | Non-steroidal antiinflammatory agent | 0.192 0.078 CID_6452977 | ||
| 0.205 | 0.004 | 0.205 | NMDA receptor agonist | 0.14 0.009 CID_6452977 | ||
| 0.226 | 0.028 | 0.352 | Heat shock protein 90 antagonist | 0.352 0.005 CID_6452977 | CID_6452977 | |
| 0.216 | 0.019 | 0.216 | Arachidonic acid antagonist | 0.207 0.027 CID_6452977 | ||
| 0.231 | 0.036 | 0.231 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.261 | 0.066 | 0.261 | Gastrin inhibitor | |||
| 0.209 | 0.016 | 0.209 | Nav1.6 sodium channel blocker | 0.12 0.097 CID_6452977 | ||
| 0.195 | 0.004 | 0.195 | 5 Hydroxytryptamine 2C agonist | 0.102 0.008 CID_6452977 | ||
| 0.246 | 0.055 | 0.246 | MAP kinase kinase 2 inhibitor | |||
| 0.261 | 0.071 | 0.261 | Interleukin agonist | 0.174 0.145 CID_6452977 | ||
| 0.259 | 0.069 | 0.259 | Superoxide dismutase inhibitor | 0.211 0.105 CID_6452977 | ||
| 0.196 | 0.006 | 0.196 | Cyclin B3 inhibitor | 0.092 0.032 CID_6452977 | ||
| 0.248 | 0.058 | 0.248 | Neuropeptide Y2 antagonist | 0.181 0.158 CID_6452977 | ||
| 0.2 | 0.013 | 0.2 | Interleukin 8 antagonist | 0.154 0.032 CID_6452977 | ||
| 0.198 | 0.011 | 0.198 | Pregnane X receptor agonist | 0.16 0.037 CID_6452977 | ||
| 0.215 | 0.032 | 0.215 | c-Src kinase inhibitor | 0.206 0.034 CID_6452977 | ||
| 0.188 | 0.005 | 0.188 | NMDA receptor subunit 3B antagonist | 0.158 0.005 CID_6452977 | ||
| 0.205 | 0.023 | 0.205 | Nav1.3 sodium channel blocker | |||
| 0.196 | 0.015 | 0.196 | EphA2 antagonist | |||
| 0.207 | 0.027 | 0.207 | Cell wall synthesis inhibitor | 0.171 0.047 CID_6452977 | ||
| 0.275 | 0.095 | 0.461 | 12-Lipoxygenase inhibitor | 0.461 0.027 CID_6452977 | CID_6452977 | |
| 0.193 | 0.014 | 0.193 | Nav1.5 sodium channel blocker | |||
| 0.184 | 0.005 | 0.184 | Ca2+-transporting ATPase inhibitor | 0.174 0.01 CID_6452977 | ||
| 0.179 | 0.004 | 0.179 | 5 Hydroxytryptamine 2 agonist | 0.126 0.006 CID_6452977 | ||
| 0.22 | 0.046 | 0.245 | Amyloid beta precursor protein antagonist | 0.245 0.035 CID_6452977 | CID_6452977 | |
| 0.186 | 0.012 | 0.189 | NADH dehydrogenase inhibitor | 0.189 0.011 CID_6452977 | CID_6452977 | |
| 0.206 | 0.032 | 0.206 | Nav1.2 sodium channel blocker | |||
| 0.187 | 0.014 | 0.187 | HIV-1 integrase (Overall Integration) inhibitor | 0.159 0.022 CID_6452977 | ||
| 0.298 | 0.125 | 0.298 | Histamine release inhibitor | 0.211 0.189 CID_6452977 | ||
| 0.184 | 0.014 | 0.184 | Alcohol dehydrogenase inhibitor | 0.136 0.025 CID_6452977 | ||
| 0.203 | 0.033 | 0.203 | NADPH oxidase inhibitor | 0.123 0.079 CID_6452977 | ||
| 0.183 | 0.014 | 0.185 | Creatine kinase inhibitor | 0.185 0.013 CID_6452977 | CID_6452977 | |
| 0.173 | 0.004 | 0.173 | NMDA receptor glycine site agonist | 0.135 0.005 CID_6452977 | ||
| 0.183 | 0.014 | 0.183 | Hedgehog signaling inhibitor | |||
| 0.222 | 0.053 | 0.222 | LIM domain kinase 1 inhibitor | |||
| 0.179 | 0.012 | 0.179 | GABA C receptor rho-1 antagonist | 0.118 0.042 CID_6452977 | ||
| 0.176 | 0.009 | 0.176 | MAP kinase kinase 1 inhibitor | 0.151 0.016 CID_6452977 | ||
| 0.21 | 0.043 | 0.21 | Antipruritic | |||
| 0.198 | 0.034 | 0.198 | Alkaline phosphatase inhibitor | 0.158 0.055 CID_6452977 | ||
| 0.178 | 0.015 | 0.178 | AMP-activated protein kinase stimulant | 0.14 0.035 CID_6452977 | ||
| 0.205 | 0.042 | 0.302 | Diuretic | 0.302 0.022 CID_6452977 | CID_6452977 | |
| 0.182 | 0.022 | 0.182 | Sphingosine 1-phosphate receptor 5 antagonist | 0.147 0.066 CID_6452977 | ||
| 0.166 | 0.007 | 0.166 | Cannabinoid CB2 receptor antagonist | 0.06 0.03 CID_6452977 | ||
| 0.164 | 0.006 | 0.164 | Potassium channel Kv1.5 blocker | |||
| 0.174 | 0.016 | 0.174 | p38 MAP kinase inhibitor | |||
| 0.161 | 0.005 | 0.161 | Dopamine transporter inhibitor | 0.113 0.009 CID_6452977 | ||
| 0.188 | 0.033 | 0.188 | MAP kinase kinase inhibitor | 0.142 0.056 CID_6452977 | ||
| 0.199 | 0.045 | 0.227 | Amylase inhibitor | 0.227 0.035 CID_6452977 | CID_6452977 | |
| 0.196 | 0.042 | 0.207 | Interferon gamma antagonist | 0.207 0.038 CID_6452977 | CID_6452977 | |
| 0.171 | 0.019 | 0.171 | DNA directed RNA polymerase inhibitor | 0.11 0.045 CID_6452977 | ||
| 0.165 | 0.016 | 0.165 | Triose-phosphate isomerase inhibitor | 0.121 0.032 CID_6452977 | ||
| 0.154 | 0.005 | 0.181 | NMDA receptor subunit 3A antagonist | 0.181 0.004 CID_6452977 | CID_6452977 | |
| 0.231 | 0.082 | 0.231 | DNA synthesis inhibitor | 0.195 0.13 CID_6452977 | ||
| 0.161 | 0.013 | 0.161 | Cell adhesion molecule inhibitor | |||
| 0.169 | 0.022 | 0.169 | Sphingosine 1-phosphate receptor 2 antagonist | 0.136 0.063 CID_6452977 | ||
| 0.263 | 0.118 | 0.32 | Transcription factor NF kappa B inhibitor | 0.32 0.086 CID_6452977 | CID_6452977 | |
| 0.148 | 0.004 | 0.148 | Exportin-1 inhibitor | 0.087 0.017 CID_6452977 | ||
| 0.229 | 0.086 | 0.229 | Calpain inhibitor | |||
| 0.15 | 0.007 | 0.15 | Glycine receptor antagonist | 0.116 0.02 CID_6452977 | ||
| 0.187 | 0.045 | 0.187 | Thiol protease inhibitor | |||
| 0.145 | 0.003 | 0.145 | Somatostatin 2 agonist | 0.018 0.008 CID_6452977 | ||
| 0.161 | 0.02 | 0.161 | Beta glucuronidase inhibitor | 0.147 0.026 CID_6452977 | ||
| 0.206 | 0.067 | 0.206 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.176 0.098 CID_6452977 | ||
| 0.172 | 0.034 | 0.172 | Cell adhesion inhibitor | |||
| 0.16 | 0.024 | 0.16 | Catalase inhibitor | 0.087 0.044 CID_6452977 | ||
| 0.183 | 0.047 | 0.183 | Hexokinase inhibitor | 0.143 0.087 CID_6452977 | ||
| 0.175 | 0.039 | 0.175 | MAP kinase 3 inhibitor | 0.127 0.115 CID_6452977 | ||
| 0.212 | 0.077 | 0.212 | ErbB-1 antagonist | |||
| 0.279 | 0.144 | 0.471 | 15-Lipoxygenase inhibitor | 0.471 0.047 CID_6452977 | CID_6452977 | |
| 0.171 | 0.038 | 0.171 | Neuropeptide Y1 antagonist | 0.126 0.108 CID_6452977 | ||
| 0.22 | 0.086 | 0.22 | Antiamyloidogenic | 0.185 0.111 CID_6452977 | ||
| 0.24 | 0.106 | 0.24 | Insulysin inhibitor | 0.228 0.119 CID_6452977 | ||
| 0.183 | 0.052 | 0.183 | Interleukin 6 antagonist | |||
| 0.147 | 0.018 | 0.147 | Glutamate receptor agonist | 0.079 0.054 CID_6452977 | ||
| 0.138 | 0.01 | 0.138 | GABA aminotransferase inhibitor | 0.112 0.019 CID_6452977 | ||
| 0.141 | 0.013 | 0.141 | Prostaglandin-E synthase inhibitor | 0.073 0.046 CID_6452977 | ||
| 0.135 | 0.008 | 0.135 | D-Ala-D-Ala ligase inhibitor | 0.135 0.008 CID_6452977 | ||
| 0.131 | 0.005 | 0.131 | Potassium channel intermediate-conductance Ca-activated blocker | 0.055 0.053 CID_6452977 | ||
| 0.145 | 0.02 | 0.145 | MAP kinase 14 inhibitor | |||
| 0.135 | 0.012 | 0.135 | Dopamine uptake inhibitor | 0.105 0.017 CID_6452977 | ||
| 0.127 | 0.005 | 0.127 | Glutamate (mGluR6) antagonist | 0.098 0.011 CID_6452977 | ||
| 0.146 | 0.024 | 0.146 | DOPA decarboxylase inhibitor | 0.146 0.023 CID_6452977 | ||
| 0.144 | 0.022 | 0.213 | Interleukin 2 antagonist | 0.213 0.006 CID_6452977 | CID_6452977 | |
| 0.181 | 0.059 | 0.181 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.206 | 0.086 | 0.215 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.215 0.08 CID_6452977 | CID_6452977 | |
| 0.132 | 0.012 | 0.132 | Benzodiazepine agonist | |||
| 0.184 | 0.064 | 0.23 | Mcl-1 antagonist | 0.23 0.043 CID_6452977 | CID_6452977 | |
| 0.137 | 0.018 | 0.137 | Glutamate (mGluR7) agonist | |||
| 0.124 | 0.006 | 0.124 | GABA B receptor agonist | 0.109 0.011 CID_6452977 | ||
| 0.174 | 0.057 | 0.174 | Neurotensin receptor agonist | 0.154 0.092 CID_6452977 | ||
| 0.144 | 0.028 | 0.155 | Transcription factor STAT6 inhibitor | 0.155 0.02 CID_6452977 | CID_6452977 | |
| 0.246 | 0.13 | 0.246 | Vasodilator, peripheral | 0.208 0.167 CID_6452977 | ||
| 0.152 | 0.037 | 0.152 | Aminopeptidase B inhibitor | 0.114 0.056 CID_6452977 | ||
| 0.129 | 0.015 | 0.129 | Nav1.7 sodium channel blocker | |||
| 0.143 | 0.029 | 0.143 | Adenylate kinase inhibitor | 0.112 0.052 CID_6452977 | ||
| 0.127 | 0.013 | 0.127 | T cell inhibitor | 0.103 0.022 CID_6452977 | ||
| 0.138 | 0.024 | 0.138 | Potassium channel activator | |||
| 0.139 | 0.026 | 0.139 | Androgen antagonist | 0.128 0.03 CID_6452977 | ||
| 0.122 | 0.009 | 0.122 | 5 Hydroxytryptamine 2A agonist | 0.069 0.038 CID_6452977 | ||
| 0.178 | 0.066 | 0.178 | Src kinase inhibitor | 0.156 0.079 CID_6452977 | ||
| 0.117 | 0.004 | 0.117 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.149 | 0.036 | 0.149 | GABA receptor agonist | |||
| 0.115 | 0.004 | 0.115 | CC chemokine 4 receptor antagonist | 0.055 0.02 CID_6452977 | ||
| 0.133 | 0.022 | 0.133 | Histamine N-methyltransferase inhibitor | 0.081 0.065 CID_6452977 | ||
| 0.164 | 0.054 | 0.164 | CF transmembrane conductance regulator agonist | 0.138 0.1 CID_6452977 | ||
| 0.115 | 0.005 | 0.115 | Corticotropin releasing factor 2 receptor antagonist | 0.067 0.033 CID_6452977 | ||
| 0.152 | 0.042 | 0.152 | Heat shock protein 70 antagonist | 0.137 0.089 CID_6452977 | ||
| 0.157 | 0.049 | 0.157 | Cyclooxygenase 2 inhibitor | |||
| 0.128 | 0.022 | 0.128 | NMDA 2 receptor antagonist | 0.072 0.05 CID_6452977 | ||
| 0.113 | 0.007 | 0.113 | Somatostatin agonist | |||
| 0.161 | 0.056 | 0.161 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.136 | 0.031 | 0.136 | Urease inhibitor | 0.13 0.036 CID_6452977 | ||
| 0.13 | 0.025 | 0.13 | Porphobilinogen synthase inhibitor | 0.116 0.029 CID_6452977 | ||
| 0.114 | 0.009 | 0.114 | Vanilloid 4 agonist | 0.083 0.035 CID_6452977 | ||
| 0.141 | 0.037 | 0.141 | Protein kinase C gamma inhibitor | |||
| 0.266 | 0.163 | 0.376 | Antibacterial | 0.376 0.088 CID_6452977 | CID_6452977 | |
| 0.15 | 0.047 | 0.15 | Aldehyde dehydrogenase inhibitor | 0.114 0.077 CID_6452977 | ||
| 0.116 | 0.015 | 0.116 | Cannabinoid CB1 receptor agonist | |||
| 0.113 | 0.012 | 0.113 | NMDA 2C receptor antagonist | 0.079 0.026 CID_6452977 | ||
| 0.105 | 0.004 | 0.105 | Kainate receptor 2 antagonist | 0.056 0.013 CID_6452977 | ||
| 0.107 | 0.007 | 0.107 | Kainate receptor antagonist | 0.051 0.021 CID_6452977 | ||
| 0.13 | 0.03 | 0.136 | Anabolic | 0.136 0.026 CID_6452977 | CID_6452977 | |
| 0.109 | 0.01 | 0.109 | AMPA receptor antagonist | 0.06 0.025 CID_6452977 | ||
| 0.105 | 0.007 | 0.105 | Nicotinic alpha3beta2 receptor antagonist | 0.058 0.029 CID_6452977 | ||
| 0.154 | 0.056 | 0.154 | Adenylate cyclase stimulant | 0.146 0.069 CID_6452977 | ||
| 0.224 | 0.125 | 0.342 | Hypoxia-inducible factor 1 alpha inhibitor | 0.342 0.048 CID_6452977 | CID_6452977 | |
| 0.241 | 0.143 | 0.241 | Vasodilator, coronary | 0.201 0.181 CID_6452977 | ||
| 0.102 | 0.004 | 0.102 | Pregnane X receptor antagonist | 0.102 0.004 CID_6452977 | ||
| 0.122 | 0.025 | 0.122 | MAP kinase 11 inhibitor | |||
| 0.119 | 0.023 | 0.119 | Glutamate dehydrogenase inhibitor | 0.096 0.033 CID_6452977 | ||
| 0.214 | 0.119 | 0.26 | Transcription factor STAT inhibitor | 0.26 0.08 CID_6452977 | CID_6452977 | |
| 0.099 | 0.004 | 0.099 | 5 Hydroxytryptamine 2B agonist | 0.041 0.023 CID_6452977 | ||
| 0.098 | 0.003 | 0.098 | Corticotropin releasing factor 1 receptor antagonist | 0.024 0.015 CID_6452977 | ||
| 0.197 | 0.102 | 0.303 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.303 0.063 CID_6452977 | CID_6452977 | |
| 0.158 | 0.064 | 0.158 | Cyclooxygenase inhibitor | |||
| 0.098 | 0.005 | 0.098 | Potassium channel (Inward rectifier) activator | 0.057 0.023 CID_6452977 | ||
| 0.135 | 0.042 | 0.135 | Ephrin antagonist | |||
| 0.102 | 0.01 | 0.102 | Neurokinin 2 antagonist | |||
| 0.108 | 0.016 | 0.108 | Biliverdin reductase inhibitor | 0.061 0.039 CID_6452977 | ||
| 0.109 | 0.018 | 0.109 | Carbamoyl phosphate synthetase inhibitor | 0.082 0.028 CID_6452977 | ||
| 0.137 | 0.046 | 0.137 | Alpha 2b adrenoreceptor antagonist | |||
| 0.115 | 0.024 | 0.115 | Bile acid receptor antagonist | 0.105 0.04 CID_6452977 | ||
| 0.103 | 0.013 | 0.103 | Phosphorylase inhibitor | 0.057 0.026 CID_6452977 | ||
| 0.094 | 0.003 | 0.117 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.117 0.002 CID_6452977 | CID_6452977 | |
| 0.095 | 0.005 | 0.095 | Potassium channel (ATP-sensitive) activator | 0.054 0.022 CID_6452977 | ||
| 0.112 | 0.022 | 0.112 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.183 | 0.095 | 0.183 | Histone acetyltransferase inhibitor | |||
| 0.159 | 0.071 | 0.159 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.101 | 0.013 | 0.101 | NMDA 2A receptor antagonist | 0.071 0.024 CID_6452977 | ||
| 0.129 | 0.04 | 0.437 | Estrogen antagonist | 0.437 0.004 CID_6452977 | CID_6452977 | |
| 0.093 | 0.005 | 0.093 | Glucagon receptor antagonist | 0.072 0.005 CID_6452977 | ||
| 0.092 | 0.005 | 0.092 | Potassium channel small-conductance Ca-activated activator | |||
| 0.209 | 0.122 | 0.209 | Transcription factor STAT3 inhibitor | |||
| 0.166 | 0.079 | 0.166 | Phospholipase C inhibitor | 0.15 0.107 CID_6452977 | ||
| 0.12 | 0.033 | 0.12 | Protein kinase C zeta inhibitor | 0.091 0.063 CID_6452977 | ||
| 0.112 | 0.026 | 0.112 | ATPase (Vacuolar H+) inhibitor | 0.095 0.047 CID_6452977 | ||
| 0.1 | 0.014 | 0.1 | Phospholipase D inhibitor | |||
| 0.104 | 0.018 | 0.104 | Glycine receptor agonist | 0.09 0.028 CID_6452977 | ||
| 0.096 | 0.011 | 0.096 | Potassium channel (Tandem pore domain) blocker | |||
| 0.112 | 0.027 | 0.112 | Phosphofructokinase-1 inhibitor | 0.092 0.035 CID_6452977 | ||
| 0.18 | 0.095 | 0.18 | Insulin sensitizer | |||
| 0.141 | 0.056 | 0.141 | Cyclooxygenase 3 inhibitor | 0.102 0.1 CID_6452977 | ||
| 0.139 | 0.055 | 0.139 | Cathepsin H inhibitor | |||
| 0.093 | 0.009 | 0.093 | MDM2 inhibitor | 0.066 0.05 CID_6452977 | ||
| 0.106 | 0.022 | 0.106 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.101 | 0.018 | 0.101 | Alcohol oxidase inhibitor | 0.088 0.021 CID_6452977 | ||
| 0.135 | 0.052 | 0.194 | Protein kinase (CK2) alpha inhibitor | 0.194 0.026 CID_6452977 | CID_6452977 | |
| 0.088 | 0.005 | 0.088 | Purinergic P2X7 antagonist | |||
| 0.089 | 0.007 | 0.089 | CC chemokine receptor 2B antagonist | |||
| 0.093 | 0.011 | 0.093 | Botulinum neurotoxin type A inhibitor | 0.08 0.017 CID_6452977 | ||
| 0.149 | 0.067 | 0.149 | Glycogen synthase kinase-3 alpha inhibitor | 0.108 0.096 CID_6452977 | ||
| 0.085 | 0.004 | 0.085 | NMDA receptor glycine site antagonist | 0.051 0.005 CID_6452977 | ||
| 0.117 | 0.036 | 0.378 | Estrogen receptor beta antagonist | 0.378 0.004 CID_6452977 | CID_6452977 | |
| 0.104 | 0.024 | 0.104 | Cannabinoid receptor agonist | |||
| 0.096 | 0.016 | 0.096 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.093 | 0.013 | 0.109 | Heat shock protein 90 beta antagonist | 0.109 0.009 CID_6452977 | CID_6452977 | |
| 0.087 | 0.007 | 0.087 | Dihydroorotase inhibitor | 0.052 0.022 CID_6452977 | ||
| 0.082 | 0.004 | 0.082 | Alpha 1L adrenoreceptor agonist | 0.045 0.026 CID_6452977 | ||
| 0.119 | 0.042 | 0.119 | Sphingomyelinase inhibitor | |||
| 0.132 | 0.055 | 0.132 | Beta amyloid protein antagonist | |||
| 0.081 | 0.005 | 0.081 | Glutamate (mGluR3) antagonist | 0.048 0.014 CID_6452977 | ||
| 0.081 | 0.005 | 0.081 | Benzodiazepine antagonist | 0.044 0.042 CID_6452977 | ||
| 0.22 | 0.144 | 0.38 | Prostaglandin dehydrogenase inhibitor | 0.38 0.073 CID_6452977 | CID_6452977 | |
| 0.097 | 0.023 | 0.097 | Purinergic P2 antagonist | |||
| 0.081 | 0.006 | 0.081 | Glutamate (mGluR group II) antagonist | 0.054 0.014 CID_6452977 | ||
| 0.086 | 0.012 | 0.086 | Aconitate hydratase inhibitor | 0.057 0.029 CID_6452977 | ||
| 0.086 | 0.012 | 0.086 | Sphingosine kinase 2 inhibitor | 0.063 0.028 CID_6452977 | ||
| 0.088 | 0.015 | 0.088 | Dihydroorotate dehydrogenase inhibitor | 0.055 0.033 CID_6452977 | ||
| 0.09 | 0.017 | 0.09 | Prostaglandin E2 antagonist | |||
| 0.107 | 0.035 | 0.107 | Carbonic anhydrase VI inhibitor | 0.087 0.049 CID_6452977 | ||
| 0.092 | 0.019 | 0.092 | Purinergic P2X1 antagonist | 0.086 0.022 CID_6452977 | ||
| 0.099 | 0.027 | 0.167 | Estrogen receptor alpha antagonist | 0.167 0.01 CID_6452977 | CID_6452977 | |
| 0.083 | 0.011 | 0.083 | CD45 antagonist | 0.067 0.017 CID_6452977 | ||
| 0.075 | 0.004 | 0.075 | Phenylethanolamine N methyltransferase inhibitor | 0.045 0.021 CID_6452977 | ||
| 0.13 | 0.06 | 0.131 | Adenylate cyclase inhibitor | 0.131 0.059 CID_6452977 | CID_6452977 | |
| 0.169 | 0.1 | 0.169 | I kappa B kinase epsilon inhibitor | |||
| 0.101 | 0.032 | 0.101 | Protein kinase B gamma inhibitor | |||
| 0.088 | 0.019 | 0.088 | Acyl-CoA dehydrogenase inhibitor | 0.051 0.042 CID_6452977 | ||
| 0.08 | 0.011 | 0.08 | Nicotinic acid receptor 1 agonist | |||
| 0.072 | 0.004 | 0.072 | Integrin alpha1beta1 antagonist | 0.043 0.015 CID_6452977 | ||
| 0.152 | 0.084 | 0.152 | Sigma receptor agonist | |||
| 0.116 | 0.047 | 0.116 | Carbonic anhydrase III inhibitor | 0.102 0.06 CID_6452977 | ||
| 0.113 | 0.045 | 0.113 | Folate antagonist | |||
| 0.22 | 0.153 | 0.22 | Antithrombotic | |||
| 0.086 | 0.021 | 0.086 | Glutamate (mGluR7) antagonist | |||
| 0.094 | 0.029 | 0.094 | Phenylalanine 4-hydroxylase inhibitor | 0.09 0.031 CID_6452977 | ||
| 0.1 | 0.035 | 0.1 | Granulocyte macrophage colony stimulating factor agonist | 0.083 0.066 CID_6452977 | ||
| 0.088 | 0.023 | 0.088 | Cannabinoid CB2 receptor agonist | |||
| 0.069 | 0.005 | 0.069 | Kynurenine 3 monooxygenase inhibitor | 0.032 0.014 CID_6452977 | ||
| 0.116 | 0.051 | 0.173 | Protein kinase (CK2) inhibitor | 0.173 0.025 CID_6452977 | CID_6452977 | |
| 0.069 | 0.005 | 0.069 | LFA antagonist | 0.027 0.021 CID_6452977 | ||
| 0.096 | 0.032 | 0.096 | Glutamate decarboxylase inhibitor | 0.091 0.035 CID_6452977 | ||
| 0.086 | 0.022 | 0.086 | TRPA1 antagonist | |||
| 0.089 | 0.025 | 0.089 | Secretase beta inhibitor | |||
| 0.078 | 0.014 | 0.078 | 5 Hydroxytryptamine 7 agonist | |||
| 0.082 | 0.019 | 0.082 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.059 0.035 CID_6452977 | ||
| 0.077 | 0.015 | 0.077 | Purinergic P2X antagonist | |||
| 0.094 | 0.032 | 0.095 | Estrogen-related receptor beta agonist | 0.095 0.032 CID_6452977 | CID_6452977 | |
| 0.07 | 0.008 | 0.093 | Dopamine D5 agonist | 0.093 0.005 CID_6452977 | CID_6452977 | |
| 0.072 | 0.011 | 0.072 | Adenylate cyclase 1 inhibitor | 0.061 0.017 CID_6452977 | ||
| 0.105 | 0.044 | 0.105 | Calcium antagonist | |||
| 0.116 | 0.055 | 0.116 | Acetylcholine release stimulant | |||
| 0.131 | 0.07 | 0.131 | Cyclooxygenase 1 inhibitor | |||
| 0.073 | 0.012 | 0.073 | Antiviral (Hepatitis D) | |||
| 0.08 | 0.019 | 0.08 | Fatty acid synthase inhibitor | 0.056 0.041 CID_6452977 | ||
| 0.095 | 0.034 | 0.126 | Histidine decarboxylase inhibitor | 0.126 0.024 CID_6452977 | CID_6452977 | |
| 0.065 | 0.005 | 0.065 | Heme oxygenase inhibitor | 0.046 0.02 CID_6452977 | ||
| 0.09 | 0.03 | 0.09 | Calcium channel L-type blocker | |||
| 0.072 | 0.013 | 0.072 | Glutamate (mGluR5) agonist | |||
| 0.089 | 0.031 | 0.089 | Sphingosine 1-phosphate receptor antagonist | 0.084 0.038 CID_6452977 | ||
| 0.104 | 0.046 | 0.104 | Ca(v)2.2 blocker | |||
| 0.071 | 0.012 | 0.071 | Progesterone antagonist | 0.048 0.019 CID_6452977 | ||
| 0.07 | 0.012 | 0.07 | Glucose-6-phosphate isomerase inhibitor | 0.06 0.018 CID_6452977 | ||
| 0.08 | 0.023 | 0.08 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.095 | 0.039 | 0.095 | mTOR complex 2 inhibitor | |||
| 0.08 | 0.024 | 0.08 | Androgen agonist | 0.074 0.028 CID_6452977 | ||
| 0.132 | 0.075 | 0.132 | Calcium channel blocker | |||
| 0.076 | 0.019 | 0.076 | Calcium channel P-type blocker | |||
| 0.127 | 0.072 | 0.127 | Vanilloid 1 agonist | 0.117 0.095 CID_6452977 | ||
| 0.06 | 0.005 | 0.077 | ATP citrate lysase inhibitor | 0.077 0.004 CID_6452977 | CID_6452977 | |
| 0.063 | 0.008 | 0.063 | Nerve growth factor antagonist | 0.042 0.031 CID_6452977 | ||
| 0.064 | 0.009 | 0.064 | Alpha 1d adrenoreceptor agonist | |||
| 0.094 | 0.04 | 0.094 | Alpha 2a adrenoreceptor antagonist | |||
| 0.059 | 0.005 | 0.086 | CF transmembrane conductance regulator antagonist | 0.086 0.003 CID_6452977 | CID_6452977 | |
| 0.119 | 0.065 | 0.119 | Calcium channel N-type blocker | |||
| 0.089 | 0.035 | 0.089 | Aminopeptidase I inhibitor | 0.066 0.059 CID_6452977 | ||
| 0.076 | 0.023 | 0.076 | GABA receptor antagonist | |||
| 0.059 | 0.006 | 0.059 | Glutamate (mGluR2) antagonist | 0.036 0.014 CID_6452977 | ||
| 0.075 | 0.023 | 0.075 | GABA A receptor antagonist | |||
| 0.064 | 0.012 | 0.064 | Dopamine beta hydroxylase inhibitor | 0.062 0.013 CID_6452977 | ||
| 0.055 | 0.004 | 0.055 | Dipeptidyl peptidase IX inhibitor | |||
| 0.072 | 0.02 | 0.093 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.093 0.012 CID_6452977 | CID_6452977 | |
| 0.069 | 0.017 | 0.069 | Glutamate (mGluR group I) agonist | |||
| 0.062 | 0.011 | 0.062 | Nicotinic acid receptor agonist | 0.058 0.012 CID_6452977 | ||
| 0.066 | 0.015 | 0.066 | Immunoglobulin Fc receptor antagonist | |||
| 0.056 | 0.005 | 0.056 | Vanilloid 3 antagonist | 0.041 0.02 CID_6452977 | ||
| 0.094 | 0.043 | 0.094 | Glutathione S-transferase inhibitor | 0.087 0.051 CID_6452977 | ||
| 0.06 | 0.009 | 0.06 | p53 inhibitor | |||
| 0.076 | 0.026 | 0.076 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.096 | 0.046 | 0.096 | Bromodomain-containing protein 2 inhibitor | |||
| 0.097 | 0.047 | 0.097 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.081 | 0.032 | 0.125 | Dopamine D1 antagonist | 0.125 0.019 CID_6452977 | CID_6452977 | |
| 0.138 | 0.089 | 0.138 | Phospholipase A2 inhibitor | |||
| 0.052 | 0.004 | 0.052 | Sodium/hydrogen exchanger inhibitor | 0.02 0.008 CID_6452977 | ||
| 0.077 | 0.029 | 0.077 | 5 Hydroxytryptamine 3 agonist | |||
| 0.063 | 0.015 | 0.063 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.053 | 0.006 | 0.053 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.093 | 0.046 | 0.093 | Platelet growth factor antagonist | |||
| 0.068 | 0.021 | 0.068 | Glycine transporter inhibitor | |||
| 0.053 | 0.006 | 0.053 | Protein kinase (CK2) beta inhibitor | 0.045 0.009 CID_6452977 | ||
| 0.1 | 0.053 | 0.1 | Potassium channel (Voltage-sensitive) activator | |||
| 0.067 | 0.02 | 0.067 | Dihydroorotate oxidase inhibitor | 0.056 0.036 CID_6452977 | ||
| 0.055 | 0.009 | 0.055 | Factor XI inhibitor | |||
| 0.059 | 0.012 | 0.059 | Substance P antagonist | |||
| 0.113 | 0.067 | 0.113 | TRPA1 agonist | |||
| 0.056 | 0.01 | 0.056 | Potassium channel Kv1.1 blocker | |||
| 0.071 | 0.025 | 0.071 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.053 | 0.008 | 0.053 | Free fatty acid receptor 1 antagonist | 0.031 0.027 CID_6452977 | ||
| 0.056 | 0.012 | 0.056 | AMPA 4 receptor antagonist | 0.04 0.027 CID_6452977 | ||
| 0.05 | 0.005 | 0.057 | CXC chemokine 2 receptor antagonist | 0.057 0.005 CID_6452977 | CID_6452977 | |
| 0.063 | 0.019 | 0.063 | Heparanase inhibitor | 0.05 0.044 CID_6452977 | ||
| 0.068 | 0.023 | 0.068 | Bcl-xL inhibitor | |||
| 0.134 | 0.09 | 0.134 | Hemostatic | |||
| 0.135 | 0.091 | 0.135 | Insulin secretagoues | |||
| 0.149 | 0.105 | 0.149 | DNA methyltransferase I inhibitor | 0.147 0.107 CID_6452977 | ||
| 0.066 | 0.022 | 0.066 | Neurokinin antagonist | |||
| 0.058 | 0.015 | 0.058 | Glutamate (mGluR4) antagonist | |||
| 0.056 | 0.013 | 0.056 | Dihydrofolate reductase inhibitor | |||
| 0.069 | 0.027 | 0.069 | Prostaglandin antagonist | |||
| 0.056 | 0.014 | 0.056 | GABA B receptor antagonist | |||
| 0.052 | 0.01 | 0.052 | Integrin alpha2 antagonist | |||
| 0.078 | 0.036 | 0.078 | Acetylcholine M5 receptor agonist | |||
| 0.059 | 0.018 | 0.059 | Thymidylate synthase inhibitor | 0.048 0.03 CID_6452977 | ||
| 0.06 | 0.019 | 0.06 | Neurokinin 3 antagonist | |||
| 0.048 | 0.008 | 0.048 | Ceramide glucosyltransferase inhibitor | 0.037 0.021 CID_6452977 | ||
| 0.059 | 0.019 | 0.059 | Glutamate (mGluR group III) agonist | |||
| 0.079 | 0.038 | 0.079 | Amidase inhibitor | |||
| 0.051 | 0.011 | 0.051 | Cathepsin F inhibitor | |||
| 0.054 | 0.014 | 0.054 | Histamine H1 receptor agonist | |||
| 0.059 | 0.02 | 0.059 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.095 | 0.055 | 0.095 | Falcipain 2 inhibitor | |||
| 0.13 | 0.091 | 0.13 | Cytidine deaminase inhibitor | |||
| 0.166 | 0.127 | 0.166 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.086 | 0.047 | 0.086 | CC chemokine 5 receptor agonist | |||
| 0.063 | 0.024 | 0.063 | Epithelial sodium channel blocker | |||
| 0.138 | 0.099 | 0.156 | Melanin inhibitor | 0.156 0.073 CID_6452977 | CID_6452977 | |
| 0.117 | 0.078 | 0.117 | DNA repair enzyme inhibitor | |||
| 0.08 | 0.042 | 0.08 | HIV-1 reverse transcriptase inhibitor | |||
| 0.054 | 0.016 | 0.054 | Thymidine kinase inhibitor | 0.038 0.035 CID_6452977 | ||
| 0.067 | 0.029 | 0.067 | Carbonic anhydrase VB inhibitor | |||
| 0.062 | 0.024 | 0.062 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.07 | 0.032 | 0.07 | Cyclin B1 inhibitor | |||
| 0.134 | 0.097 | 0.175 | Protein-tyrosine phosphatase inhibitor | 0.175 0.059 CID_6452977 | CID_6452977 | |
| 0.095 | 0.058 | 0.095 | Falcipain inhibitor | |||
| 0.05 | 0.013 | 0.05 | Fumarate hydratase inhibitor | 0.035 0.023 CID_6452977 | ||
| 0.058 | 0.022 | 0.058 | Squalene epoxidase inhibitor | |||
| 0.043 | 0.006 | 0.043 | 5 Hydroxytryptamine 6 agonist | |||
| 0.126 | 0.09 | 0.126 | Activin receptor-like kinase 2 inhibitor | |||
| 0.053 | 0.018 | 0.053 | Glutamate (mGluR group III) antagonist | |||
| 0.045 | 0.009 | 0.045 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.067 | 0.032 | 0.067 | Argininosuccinate synthase inhibitor | |||
| 0.079 | 0.044 | 0.079 | Adenosine A3 receptor antagonist | |||
| 0.053 | 0.018 | 0.053 | Dipeptidyl peptidase IV inhibitor | |||
| 0.049 | 0.015 | 0.049 | Retinoid X alpha receptor agonist | |||
| 0.175 | 0.141 | 0.175 | Spasmolytic | 0.16 0.155 CID_6452977 | ||
| 0.06 | 0.025 | 0.06 | Dipeptidyl peptidase inhibitor | |||
| 0.075 | 0.041 | 0.075 | Carbonic anhydrase VA inhibitor | |||
| 0.049 | 0.015 | 0.049 | Kainate receptor agonist | 0.04 0.032 CID_6452977 | ||
| 0.048 | 0.015 | 0.048 | Phosphoglycerate kinase inhibitor | 0.036 0.023 CID_6452977 | ||
| 0.051 | 0.017 | 0.051 | Growth hormone secretagogue receptor antagonist | |||
| 0.038 | 0.004 | 0.038 | Dipeptidyl peptidase VIII inhibitor | |||
| 0.04 | 0.007 | 0.04 | Kainate receptor 1 antagonist | |||
| 0.039 | 0.006 | 0.039 | Integrin alpha2beta1 antagonist | 0.025 0.022 CID_6452977 | ||
| 0.047 | 0.014 | 0.047 | Glutamate (mGluR8) agonist | 0.038 0.027 CID_6452977 | ||
| 0.066 | 0.033 | 0.066 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.041 | 0.008 | 0.041 | Sodium/glucose cotransporter 2 inhibitor | 0.03 0.013 CID_6452977 | ||
| 0.073 | 0.041 | 0.073 | Protein kinase C beta inhibitor | |||
| 0.06 | 0.028 | 0.06 | Thromboxane synthase inhibitor | |||
| 0.065 | 0.034 | 0.065 | EphB4 antagonist | |||
| 0.048 | 0.017 | 0.048 | TRPM8 blocker | |||
| 0.035 | 0.005 | 0.035 | Complement factor 1s inhibitor | |||
| 0.121 | 0.091 | 0.121 | Protein kinase stimulant | |||
| 0.122 | 0.092 | 0.122 | CDC-like kinase 1 inhibitor | |||
| 0.068 | 0.038 | 0.072 | Beta 3 adrenoreceptor antagonist | 0.072 0.031 CID_6452977 | CID_6452977 | |
| 0.08 | 0.05 | 0.08 | Na+ K+ transporting ATPase inhibitor | |||
| 0.08 | 0.05 | 0.08 | Carbonic anhydrase XIII inhibitor | |||
| 0.083 | 0.054 | 0.083 | Transforming growth factor beta 3 antagonist | |||
| 0.093 | 0.063 | 0.093 | Prolactin inhibitor | |||
| 0.036 | 0.006 | 0.036 | Hedgehog signaling activator | 0.029 0.016 CID_6452977 | ||
| 0.086 | 0.056 | 0.086 | Myeloperoxidase inhibitor | |||
| 0.036 | 0.006 | 0.036 | Complement factor 1r inhibitor | |||
| 0.061 | 0.032 | 0.065 | Aldose reductase inhibitor | 0.065 0.03 CID_6452977 | CID_6452977 | |
| 0.108 | 0.079 | 0.108 | Caspase 3 inhibitor | |||
| 0.037 | 0.008 | 0.037 | Purinergic P2Y15 antagonist | 0.029 0.019 CID_6452977 | ||
| 0.066 | 0.037 | 0.074 | Aromatase inhibitor | 0.074 0.031 CID_6452977 | CID_6452977 | |
| 0.037 | 0.008 | 0.037 | MAP3K8 inhibitor | |||
| 0.052 | 0.023 | 0.052 | Purinergic P2X4 antagonist | |||
| 0.105 | 0.077 | 0.105 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.105 | 0.077 | 0.105 | Calcium channel (voltage-sensitive) blocker | |||
| 0.046 | 0.018 | 0.046 | Farnesoid X receptor agonist | |||
| 0.066 | 0.038 | 0.066 | Transcription factor RelA inhibitor | |||
| 0.048 | 0.02 | 0.048 | Factor XIa inhibitor | |||
| 0.036 | 0.008 | 0.036 | Thymidine phosphorylase inhibitor | 0.025 0.02 CID_6452977 | ||
| 0.033 | 0.006 | 0.033 | Imidazoline I1 receptor antagonist | |||
| 0.039 | 0.011 | 0.039 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.041 | 0.014 | 0.041 | AMPA 1 receptor antagonist | |||
| 0.06 | 0.033 | 0.06 | Cyclin B2 inhibitor | |||
| 0.048 | 0.021 | 0.048 | Liver X receptor alpha agonist | 0.04 0.029 CID_6452977 | ||
| 0.031 | 0.004 | 0.031 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.022 0.011 CID_6452977 | ||
| 0.03 | 0.003 | 0.03 | Corticotropin releasing factor antagonist | |||
| 0.078 | 0.052 | 0.078 | MAP kinase kinase 7 inhibitor | 0.075 0.062 CID_6452977 | ||
| 0.052 | 0.026 | 0.052 | Cholesterol esterase inhibitor | |||
| 0.148 | 0.122 | 0.148 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.069 | 0.044 | 0.069 | Carbonic anhydrase V inhibitor | |||
| 0.051 | 0.026 | 0.051 | Farnesyltransferase inhibitor | |||
| 0.043 | 0.018 | 0.043 | Delayed rectifier potassium channel blocker | |||
| 0.059 | 0.034 | 0.059 | CC chemokine 2 receptor antagonist | |||
| 0.033 | 0.008 | 0.033 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.02 CID_6452977 | ||
| 0.063 | 0.038 | 0.063 | Alpha 2 adrenoreceptor agonist | |||
| 0.058 | 0.033 | 0.058 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.09 | 0.066 | 0.09 | MAO B inhibitor | |||
| 0.049 | 0.025 | 0.049 | Sphingosine 1-phosphate receptor agonist | |||
| 0.053 | 0.029 | 0.053 | Bombesin 2 receptor antagonist | |||
| 0.049 | 0.025 | 0.049 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.04 | 0.016 | 0.04 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.053 | 0.03 | 0.053 | Potassium channel (Inward rectifier) blocker | |||
| 0.052 | 0.028 | 0.052 | Histamine H4 receptor antagonist | |||
| 0.032 | 0.008 | 0.032 | Geranylgeranyltransferase inhibitor | |||
| 0.048 | 0.025 | 0.048 | Geranyltranstransferase inhibitor | |||
| 0.07 | 0.047 | 0.07 | I kappa B kinase 1 inhibitor | |||
| 0.039 | 0.016 | 0.039 | Calcium release-activated channel blocker | |||
| 0.037 | 0.014 | 0.037 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.043 | 0.02 | 0.043 | Diamine oxidase inhibitor | |||
| 0.027 | 0.005 | 0.027 | Nicotinic acid receptor 1 antagonist | 0.023 0.006 CID_6452977 | ||
| 0.094 | 0.072 | 0.094 | Alpha 2c adrenoreceptor antagonist | |||
| 0.031 | 0.01 | 0.031 | Sodium/glucose cotransporter inhibitor | 0.026 0.018 CID_6452977 | ||
| 0.068 | 0.047 | 0.068 | CDC7 inhibitor | |||
| 0.06 | 0.039 | 0.06 | Sphingosine kinase inhibitor | |||
| 0.025 | 0.004 | 0.025 | CC chemokine 9 receptor antagonist | 0.016 0.015 CID_6452977 | ||
| 0.057 | 0.036 | 0.057 | Cyclin B inhibitor | |||
| 0.036 | 0.016 | 0.036 | Cholesterol ester transfer protein antagonist | 0.032 0.021 CID_6452977 | ||
| 0.026 | 0.006 | 0.026 | Alpha 2a adrenoreceptor agonist | |||
| 0.103 | 0.083 | 0.103 | Photosensitizer | |||
| 0.073 | 0.053 | 0.073 | Acetylcholine M4 receptor antagonist | |||
| 0.104 | 0.084 | 0.104 | Microtubule formation inhibitor | |||
| 0.059 | 0.039 | 0.059 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.024 | 0.005 | 0.024 | Complement factor D inhibitor | |||
| 0.115 | 0.096 | 0.115 | Interleukin 1 antagonist | |||
| 0.134 | 0.115 | 0.134 | CDC-like kinase 4 inhibitor | |||
| 0.038 | 0.019 | 0.038 | Sirtuin 2 inhibitor | |||
| 0.092 | 0.073 | 0.092 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.057 | 0.039 | 0.057 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.025 | 0.007 | 0.025 | Cyclin T1 inhibitor | |||
| 0.056 | 0.037 | 0.056 | Glucosylceramidase inhibitor | |||
| 0.055 | 0.036 | 0.055 | Toll-Like receptor 8 antagonist | |||
| 0.031 | 0.013 | 0.031 | Myristoyl transferase inhibitor | |||
| 0.036 | 0.018 | 0.036 | Dipeptidyl peptidase II inhibitor | |||
| 0.06 | 0.043 | 0.06 | Cyclin D1 inhibitor | |||
| 0.048 | 0.031 | 0.048 | Aldosterone antagonist | |||
| 0.052 | 0.035 | 0.052 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.022 | 0.005 | 0.022 | Thromboxane A2 agonist | 0.015 0.012 CID_6452977 | ||
| 0.079 | 0.063 | 0.079 | Caspase 7 inhibitor | |||
| 0.07 | 0.053 | 0.07 | Cathepsin G inhibitor | |||
| 0.08 | 0.063 | 0.08 | GABA A receptor agonist | |||
| 0.026 | 0.01 | 0.026 | ICAM 1 antagonist | |||
| 0.081 | 0.065 | 0.081 | Alpha 2 adrenoreceptor antagonist | |||
| 0.033 | 0.017 | 0.033 | Liver X receptor beta antagonist | 0.028 0.021 CID_6452977 | ||
| 0.044 | 0.028 | 0.044 | Histamine H2 receptor agonist | |||
| 0.043 | 0.028 | 0.043 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.166 | 0.15 | 0.166 | DNA damaging | |||
| 0.02 | 0.004 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.012 0.011 CID_6452977 | ||
| 0.02 | 0.005 | 0.02 | Integrin beta2 antagonist | |||
| 0.038 | 0.023 | 0.038 | Bradykinin antagonist | |||
| 0.033 | 0.018 | 0.033 | AMPA 3 receptor antagonist | |||
| 0.031 | 0.016 | 0.031 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.036 | 0.022 | 0.036 | RNA-directed RNA polymerase inhibitor | 0.035 0.023 CID_6452977 | ||
| 0.082 | 0.068 | 0.082 | Interleukin 5 antagonist | |||
| 0.019 | 0.005 | 0.019 | Integrin alphaLbeta2 antagonist | |||
| 0.025 | 0.011 | 0.025 | Isoleucine-tRNA ligase inhibitor | |||
| 0.037 | 0.023 | 0.037 | Glycine transporter 1 inhibitor | |||
| 0.041 | 0.027 | 0.041 | Acid-sensing ion channel blocker | |||
| 0.025 | 0.012 | 0.025 | Glutamate (mGluR1a) agonist | |||
| 0.076 | 0.063 | 0.076 | Acetylcholine nicotinic agonist | |||
| 0.072 | 0.059 | 0.072 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.069 0.062 CID_6452977 | ||
| 0.056 | 0.044 | 0.056 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.052 0.051 CID_6452977 | ||
| 0.037 | 0.025 | 0.037 | Arginase inhibitor | |||
| 0.017 | 0.005 | 0.017 | Carbonic anhydrase XI inhibitor | |||
| 0.021 | 0.009 | 0.021 | G-protein-coupled receptor 120 agonist | |||
| 0.036 | 0.025 | 0.036 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.031 | 0.021 | 0.031 | Prostaglandin agonist | |||
| 0.026 | 0.015 | 0.026 | Vanilloid 2 agonist | 0.024 0.022 CID_6452977 | ||
| 0.042 | 0.031 | 0.042 | Guanylate cyclase inhibitor | |||
| 0.073 | 0.062 | 0.073 | Macrophage migration inhibitory factor inhibitor | |||
| 0.027 | 0.017 | 0.027 | Nicotinic acid receptor 2 antagonist | |||
| 0.051 | 0.041 | 0.051 | Alpha-mannosidase inhibitor | |||
| 0.09 | 0.08 | 0.09 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.034 | 0.024 | 0.034 | Glutamate (mGluR4) agonist | |||
| 0.022 | 0.012 | 0.022 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.024 | 0.015 | 0.024 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.049 | 0.04 | 0.049 | Ornithine carbamoyltransferase inhibitor | |||
| 0.1 | 0.091 | 0.1 | MAO inhibitor | |||
| 0.09 | 0.08 | 0.09 | Nav1.1 sodium channel blocker | |||
| 0.119 | 0.11 | 0.119 | Acetylcholine M1 receptor antagonist | |||
| 0.048 | 0.039 | 0.048 | Carbonic anhydrase XII inhibitor | |||
| 0.062 | 0.053 | 0.062 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.013 | 0.004 | 0.013 | Progesterone receptor A antagonist | |||
| 0.032 | 0.023 | 0.039 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.039 0.016 CID_6452977 | CID_6452977 | |
| 0.055 | 0.046 | 0.055 | Calcium channel T-type blocker | |||
| 0.036 | 0.028 | 0.036 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.035 | 0.027 | 0.035 | Inosine monophosphate dehydrogenase inhibitor | 0.033 0.03 CID_6452977 | ||
| 0.033 | 0.026 | 0.033 | Glutamate (mGluR group II) agonist | |||
| 0.023 | 0.016 | 0.023 | Prostaglandin E2 agonist | |||
| 0.072 | 0.065 | 0.072 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.034 | 0.026 | 0.034 | Retinoid X receptor agonist | |||
| 0.056 | 0.049 | 0.056 | Glutamate (mGluR) agonist | |||
| 0.017 | 0.01 | 0.017 | Nicotinic alpha4 receptor agonist | |||
| 0.027 | 0.02 | 0.027 | Bradykinin B1 receptor antagonist | |||
| 0.057 | 0.05 | 0.057 | Phosphodiesterase 1A inhibitor | |||
| 0.034 | 0.027 | 0.034 | Adenosine uptake inhibitor | |||
| 0.012 | 0.006 | 0.012 | Thromboxane agonist | |||
| 0.01 | 0.004 | 0.01 | DNA topoisomerase III inhibitor | |||
| 0.032 | 0.025 | 0.103 | Estrogen receptor alpha agonist | 0.103 0.008 CID_6452977 | CID_6452977 | |
| 0.03 | 0.024 | 0.03 | Glutamate (mGluR2) agonist | |||
| 0.019 | 0.013 | 0.019 | Alpha 2b adrenoreceptor agonist | |||
| 0.021 | 0.014 | 0.021 | Retinoid X beta receptor antagonist | |||
| 0.025 | 0.018 | 0.025 | Prostaglandin H2 antagonist | |||
| 0.029 | 0.023 | 0.029 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.039 | 0.033 | 0.039 | Sphingosine kinase 1 inhibitor | |||
| 0.023 | 0.017 | 0.023 | CC chemokine 1 receptor antagonist | |||
| 0.026 | 0.021 | 0.026 | Uridine phosphorylase inhibitor | |||
| 0.049 | 0.044 | 0.049 | Acetylcholine muscarinic agonist | |||
| 0.024 | 0.018 | 0.024 | Kainate receptor 4 antagonist | |||
| 0.015 | 0.01 | 0.015 | NMDA receptor phencyclidine site antagonist | |||
| 0.06 | 0.055 | 0.06 | Bcl2 antagonist | |||
| 0.037 | 0.032 | 0.037 | GABA uptake inhibitor | |||
| 0.048 | 0.044 | 0.05 | Carbonic anhydrase IX inhibitor | 0.05 0.042 CID_6452977 | CID_6452977 | |
| 0.042 | 0.038 | 0.052 | Carbonic anhydrase VII inhibitor | 0.052 0.026 CID_6452977 | CID_6452977 | |
| 0.037 | 0.033 | 0.037 | Neurokinin 1 antagonist | |||
| 0.031 | 0.027 | 0.031 | Liver X receptor beta agonist | |||
| 0.048 | 0.045 | 0.048 | Carbonic anhydrase I inhibitor | |||
| 0.029 | 0.025 | 0.029 | HCV NS5B polymerase inhibitor | 0.028 0.026 CID_6452977 | ||
| 0.052 | 0.048 | 0.052 | Cathepsin L inhibitor | |||
| 0.008 | 0.004 | 0.008 | DNA polymerase III subunit alpha inhibitor | |||
| 0.03 | 0.027 | 0.03 | GHS receptor antagonist | |||
| 0.135 | 0.132 | 0.135 | DNA methylase inhibitor | |||
| 0.094 | 0.091 | 0.094 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.036 | 0.033 | 0.036 | Dihydropteroate synthase inhibitor | |||
| 0.016 | 0.014 | 0.016 | Telomerase stimulant | |||
| 0.093 | 0.091 | 0.093 | Abl kinase inhibitor | |||
| 0.02 | 0.018 | 0.02 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.03 | 0.028 | 0.03 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.031 | 0.029 | 0.031 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.024 | 0.022 | 0.024 | Acid ceramidase inhibitor | |||
| 0.027 | 0.025 | 0.027 | Vasopressin 1A agonist | |||
| 0.037 | 0.035 | 0.037 | Oxytocin agonist | |||
| 0.079 | 0.078 | 0.079 | Pim-3 kinase inhibitor | |||
| 0.066 | 0.065 | 0.066 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.015 | 0.014 | 0.015 | Carbonic anhydrase VIII inhibitor | |||
| 0.015 | 0.014 | 0.015 | Carbonic anhydrase X inhibitor | |||
| 0.036 | 0.035 | 0.036 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.132 | 0.133 | 0.144 | Pyruvate kinase inhibitor | 0.144 0.121 CID_6452977 | CID_6452977 | |
| 0.022 | 0.028 | 0.026 | Thyroid hormone agonist | 0.026 0.017 CID_6452977 | CID_6452977 | |
| 0.033 | 0.039 | 0.051 | Estradiol 17 beta-dehydrogenase inhibitor | 0.051 0.024 CID_6452977 | CID_6452977 | |
| 0.169 | 0.178 | 0.274 | Lipoxygenase inhibitor | 0.274 0.084 CID_6452977 | CID_6452977 | |
| 0.014 | 0.028 | 0.022 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.022 0.016 CID_6452977 | CID_6452977 | |
| 0.117 | 0.134 | 0.122 | CC chemokine 6 receptor antagonist | 0.122 0.106 CID_6452977 | CID_6452977 | |
| 0.049 | 0.073 | 0.137 | CDC25B inhibitor | 0.137 0.008 CID_6452977 | CID_6452977 | |
| 0.132 | 0.157 | 0.146 | Hypolipemic | 0.146 0.141 CID_6452977 | CID_6452977 | |
| 0.01 | 0.047 | 0.136 | Estrogen receptor beta agonist | 0.136 0.008 CID_6452977 | CID_6452977 | |
| 0.023 | 0.064 | 0.035 | Estrogen-related receptor beta antagonist | 0.035 0.018 CID_6452977 | CID_6452977 | |
| 0.019 | 0.07 | 0.085 | Dopamine D5 antagonist | 0.085 0.011 CID_6452977 | CID_6452977 | |
| 0.091 | 0.15 | 0.154 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.154 0.07 CID_6452977 | CID_6452977 | |
| 0.014 | 0.074 | 0.069 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.069 0.008 CID_6452977 | CID_6452977 | |
| 0.118 | 0.19 | 0.164 | Immunostimulant | 0.164 0.143 CID_6452977 | CID_6452977 | |
| 0.105 | 0.195 | 0.351 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.351 0.035 CID_6452977 | CID_6452977 | |
| 0.013 | 0.103 | 0.128 | Estrogen agonist | 0.128 0.013 CID_6452977 | CID_6452977 | |
| 0.01 | 0.102 | 0.016 | Antibiotic Tetracycline-like | 0.016 0.008 CID_6452977 | CID_6452977 | |
| 0.029 | 0.131 | 0.089 | Dopamine agonist | 0.089 0.032 CID_6452977 | CID_6452977 | |
| 0.038 | 0.144 | 0.054 | Adenine nucleotide translocase inhibitor | 0.054 0.044 CID_6452977 | CID_6452977 | |
| 0.091 | 0.206 | 0.199 | Interleukin antagonist | 0.199 0.085 CID_6452977 | CID_6452977 | |
| 0.095 | 0.216 | 0.384 | Dyrk kinase inhibitor | 0.384 0.029 CID_6452977 | CID_6452977 | |
| 0.005 | 0.147 | 0.017 | Thyroid hormone alpha antagonist | 0.017 0.009 CID_6452977 | CID_6452977 | |
| 0.091 | 0.237 | 0.133 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.133 0.132 CID_6452977 | CID_6452977 | |
| 0.032 | 0.191 | 0.098 | Fibroblast growth factor 1 antagonist | 0.098 0.059 CID_6452977 | CID_6452977 | |
| 0.124 | 0.294 | 0.463 | Immunosuppressant | 0.463 0.043 CID_6452977 | CID_6452977 | |
| 0.075 | 0.248 | 0.156 | Dual specificity phosphatase inhibitor | 0.156 0.087 CID_6452977 | CID_6452977 | |
| 0.006 | 0.232 | 0.038 | Dopamine D1 agonist | 0.038 0.006 CID_6452977 | CID_6452977 | |
| 0.028 | 0.26 | 0.104 | HIV-1 integrase inhibitor | 0.104 0.023 CID_6452977 | CID_6452977 | |
| 0.047 | 0.338 | 0.188 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.188 0.071 CID_6452977 | CID_6452977 | |
| 0.09 | 0.463 | 0.238 | Caspase 3 stimulant | 0.238 0.124 CID_6452977 | CID_6452977 | |
| 0.022 | 0.456 | 0.216 | Uric acid excretion stimulant | 0.216 0.011 CID_6452977 | CID_6452977 | |
| 0.006 | 0.479 | 0.097 | HIV-1 integrase (Strand Transfer) inhibitor | 0.097 0.024 CID_6452977 | CID_6452977 | |
| 0.006 | 0.492 | 0.107 | HIV-1 integrase (3'-Processing) inhibitor | 0.107 0.024 CID_6452977 | CID_6452977 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |